Clinical Trials · NCT05151484

Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover

Active Not RecruitingPhase 4Teriparatide (Investigational)
Phase
Phase 4
Recruitment status
Active Not Recruiting
Sponsor
Madhumathi Rao
Enrollment
60
Start date
Mar 2022
Locations
1 site, United States
Primary endpoint
Mineral Bone Density of the lumbar spine
View Teriparatide compound reference